Keyphrases
Myelodysplastic Syndrome
83%
Clonal Hematopoiesis
56%
Acute Myeloid Leukemia
45%
Confidence Interval
32%
Myeloproliferative Neoplasms
30%
SNP Array
29%
Post-transplantation Cyclophosphamide (PTCy)
27%
Metaphase Cytogenetics
27%
Myelodysplastic
21%
Relapse-free Survival
20%
Myeloid Malignancies
19%
Overall Survival
18%
Graft-versus-host Disease (GvHD)
18%
Allogeneic Blood or Marrow Transplantation
15%
Acute Lymphoblastic Leukemia
13%
Hematopoietic Cell Transplantation
13%
Allogeneic Transplantation
13%
Hypomethylating Agents
13%
Genomic Landscape
13%
Hedgehog
13%
Neoplasms
13%
ASXL1
12%
Heteroplasmy
12%
Leukemia
12%
Myelodysplastic Syndrome/myeloproliferative Neoplasm
11%
Minimal Residual Disease
11%
Clonality
11%
Clonal Hematopoiesis of Indeterminate Potential
11%
Array-based
11%
Hematological Malignancies
11%
Recurrent mutation
10%
All-cause Mortality
10%
Epigenetic Modification
10%
Dasatinib
10%
Enhancer of Zeste Homolog 2 (EZH2)
10%
SETBP1
10%
Secondary Acute Myeloid Leukemia (sAML)
9%
Leukemia Patients
9%
Somatic mutation
9%
Peripheral Blood
9%
Myeloablative Conditioning
9%
Transplant Outcomes
9%
Immunodominant
9%
Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)
9%
Overlap Syndrome
9%
Isocitrate Dehydrogenase 1 (IDH1)
8%
Chromosomal Disorders
8%
Del(20q)
8%
Allogeneic Bone Marrow Transplantation
8%
Hazard Ratio
8%
Biochemistry, Genetics and Molecular Biology
Myeloid
100%
Single-Nucleotide Polymorphism
64%
Cytogenetics
56%
Metaphase
45%
Karyotyping
44%
Uniparental Disomy
36%
Hematopoiesis
35%
SNP Array
19%
Somatic Mutation
18%
Bone Marrow Failure
15%
Epigenetics
15%
Stem Cell
14%
Cell Transplantation
13%
Reprogramming
13%
Cytotoxic T Cell
13%
Heteroplasmy
13%
Clonal Variation
12%
Clonality
11%
All Cause Mortality
11%
Genetics
10%
Single Nucleotide Polymorphism
10%
ASXL1
10%
Chromosomal Abnormalities
10%
Methylation
9%
RUNX1
9%
EZH2
9%
KMT2A
9%
Precursor
9%
Progenitor Cell
9%
Missense
9%
Loss of Heterozygosity
8%
T Cell Receptor
8%
Allele
8%
Monosomy
7%
SF3B1
7%
DNA Methylation
7%
T Cell
7%
Hedgehog
6%
Fluorescence in Situ Hybridization
6%
Promoter Region
6%
Antineoplastic Activity
6%
Hematopoietic Stem Cell
6%
Chromosome Arm
6%
Serine
6%
Cell Clone
6%
Philadelphia Chromosome
6%
Gene Frequency
6%
Germ Cell
6%
Germline
6%
Mitochondrial DNA
6%
Medicine and Dentistry
Hematopoiesis
81%
Myelodysplastic Syndrome
54%
Acute Myeloid Leukemia
46%
Hematopoietic Stem Cell
25%
Disease
24%
Overall Survival
23%
Myeloproliferative Neoplasm
23%
Transplantation
23%
Cyclophosphamide
21%
Cell Transplantation
18%
Hazard Ratio
17%
Neoplasm
16%
Bone Marrow Failure
15%
Myeloid Malignancy
15%
Recurrence Free Survival
14%
Minimal Residual Disease
13%
Somatic Mutation
13%
Diagnosis
11%
Hematologic Malignancy
11%
Hematopoietic Stem Cell
11%
Leukemia
10%
ASXL1
9%
Prevalence
9%
Cancer
8%
Morphology
8%
Overlap Syndrome
8%
Marrow Failure Syndrome
8%
Graft Versus Host Reaction
8%
Precursor
7%
Drug Megadose
7%
Prophylaxis
7%
Myeloid Leukemia
7%
Atherosclerosis
7%
Janus Kinase
7%
Antineoplastic Activity
6%
Neutrophilia
6%
Chemokine Receptor
6%
FMS-Like Tyrosine Kinase 3
6%
Sickle-Cell Disease
6%
Hypomethylating Agent
6%
Cell-Free DNA
6%
Allotransplantation
6%
Cytotoxic T-Cell
6%
Tagraxofusp
6%
Myelofibrosis
6%
T-Cell Response
6%
Promoter Region
6%
Aplastic Anemia
6%
Acute Lymphoblastic Leukemia
6%
All Cause Mortality
6%
